Fractionation of low molecular weight heparin species and their interaction with antithrombin.
about
Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.Multiple functional domains of the heparin moleculeMapping the heparin-binding sites on type I collagen monomers and fibrils.Evaluation of critical groups required for the binding of heparin to antithrombin.Circular dichroism spectroscopy of heparin-antithrombin interactionsDefining the domains of type I collagen involved in heparin- binding and endothelial tube formation.Detection of a new heparin-dependent inhibitor of thrombin in human plasma.Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.Understanding the time course of pharmacological effect: a PKPD approach.HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.Glycosaminoglycans and the regulation of blood coagulation.Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesionImmunoglobulin-sulfated polysaccharide interactions. Binding of agaropectin and heparin by human IgG proteins.Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparinApplications of phasor plots to in vitro protein studies.Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.The multiple complexes formed by the interaction of platelet factor 4 with heparin.Mechanism of inactivation of trypsin by antithrombin.The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.Binding to antithrombin of heparin fractions with different molecular weights.
P2860
Q34052471-F4C52129-4D9B-4CEB-972E-5F499A35D4C9Q34524635-18B17626-1389-45AC-A7B0-9B215CDDF00DQ35416424-AFDEF83A-1151-4983-8595-30C01D91B445Q36234227-8A83D55F-325F-43AC-9859-1E4AB825AF1DQ36248809-06ABD0F9-46DC-43CD-B364-A2D5000CC750Q36322607-86F9EC90-B423-4EB7-B9D8-ED89F6A8FF89Q36483511-90D2DB83-D3E0-47CF-8ADF-DF9E7A606157Q37002723-3C807284-95AF-43C7-B697-8F8DE6FD2409Q37026070-6346AADE-B3CC-40EB-9CEB-4DBA5ACB4568Q37316352-EF38F131-66F3-4DD3-B8FC-06AF3A6DBB7FQ37461866-DB3E43CA-0801-4D49-AD20-A362553557ADQ37832754-936741AF-FA9D-459F-8EB8-E098DEFCE795Q38996741-3C8915FF-1720-4804-B164-B85871E48067Q40851193-319822BC-B0E6-4CE4-887E-356822B26459Q40927170-EA89B1D5-338D-4674-80E5-F3BF237D7628Q41896828-28556E09-B4CE-48ED-9379-884F686D1AEFQ41962619-9F62A962-C507-4360-9CB6-40326A2375E2Q42063594-D44EF8FC-8F63-4B05-8D10-512A741BB784Q42159215-99CB4B22-8B11-473C-8452-2FB406DB7741Q42165347-D53E35F7-F3C3-4575-9304-E5A44DA168E1Q42165472-7187637F-F9A7-4727-8761-453541E90C97Q42673196-1BB6AADD-B2C6-41EA-AD10-712B6278DC2DQ42820775-78D5D1CC-139A-4FC6-916D-D5AD9030DA90Q42882844-76C599BE-E1DD-457C-A27C-57AE1EB36373
P2860
Fractionation of low molecular weight heparin species and their interaction with antithrombin.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Fractionation of low molecular ...... interaction with antithrombin.
@en
type
label
Fractionation of low molecular ...... interaction with antithrombin.
@en
prefLabel
Fractionation of low molecular ...... interaction with antithrombin.
@en
P2093
P1476
Fractionation of low molecular ...... interaction with antithrombin.
@en
P2093
P304
P407
P577
1979-04-01T00:00:00Z